Biotech secures CRISPR patent for COVID-19 diagnostic test

Sherlock boosts IP portfolio with exclusive US rights to patent | Technology could be used to detect malaria, TB and COVID-19.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

US appeals court restores five CRISPR patents with precedential opinion on interferences

20 July 2023 SNIPR Biome has five patents reinstated after court rules they cannot be subject to interference | Rockefeller University had challenged patents on pre-AIA, first-to-invent basis.

Americas

USPTO rules Broad owns CRISPR animal cell editing patents

1 March 2022 Patents core to the breakthrough gene-editing technology CRISPR belong to the University of Harvard and the Massachusetts Institute of Technology’s Broad Institute, the US Patent and Trademark Office has ruled.

More on this story

Big Pharma

US appeals court restores five CRISPR patents with precedential opinion on interferences

20 July 2023 SNIPR Biome has five patents reinstated after court rules they cannot be subject to interference | Rockefeller University had challenged patents on pre-AIA, first-to-invent basis.

Americas

USPTO rules Broad owns CRISPR animal cell editing patents

More on this story

Big Pharma

US appeals court restores five CRISPR patents with precedential opinion on interferences

20 July 2023 SNIPR Biome has five patents reinstated after court rules they cannot be subject to interference | Rockefeller University had challenged patents on pre-AIA, first-to-invent basis.

Americas

USPTO rules Broad owns CRISPR animal cell editing patents